Skip Navigation

Health: Drug development

pharmaCoMalariavaccine_shanghai_whotdrcrump

A rising generics industry in developing nations is helping secure access to cheap drugs for the world's poor. But controversies over patent rules could divert investment from already neglected diseases.

(Photo credit: WHO/TDR/Crump)

Opinions and Analysis

BioMed Analysis: Pooling patents for HIV drugs

A UNITAID patent pool could revolutionise HIV treatment and research in developing countries — if payment can be agreed, says Priya Shetty.

28 September 2009 | EN | FR | 中文

Home-grown vaccines are crucial for public health

Countries need to produce their own vaccines, and they need to invest in public sector capacity to do it, says Indian scientist Y. Madhavi.

23 September 2009 | EN

All countries deserve equal access to pandemic vaccines

18 August 2009 | EN
Source: New England Journal of Medicine


News and Features

Malaria vaccine strategy aims for eradication

The PATH Malaria Vaccine Initiative has outlined its ambitions for the next generation of vaccines.

6 November 2009 | EN
Source: Nature

Surge in vaccine research fails to reach neediest

Millions of children are missing out on the fruits of an explosion in vaccine development because they are too difficult to reach.

22 October 2009 | EN